Skip to main content
OUST $48.71 +7.93%
OUST logo

OUST · Ouster, Inc.

Track OUST — free
$48.71 +3.58 (+7.93%) At close · Aug 14
Market Cap
$3.51B
Shares
72.11M
All earnings calls

Earnings call · FY2025 Q1

Ouster, Inc. Q1 FY2025 Earnings Call

Ouster, Inc. Q1 FY2025 Earnings Call

Concluded May 8, 2025
May 8, 2025 45 turns
Period
FY2025 Q1
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Path to profitability and cost discipline 21 Physical AI and NVIDIA partnership 18 Software-attached business scaling 13 Customer wins across verticals 9 Product portfolio transformation 9 Tariff impact 7

Management tone

Confident

Net tone +62 · low hedging

Grounding quotes
  • “Our first quarter results demonstrate our commitment to continued operational execution.”
  • “We continue to align with our long-term framework of 30% to 50% annual revenue growth, maintaining gross margins of 35% to 40%, and operating expenses at or below third quarter 2023 levels irrespective of the patent royalty.”
  • “we are tracking to our long-term model, our revenue growth and seeing just a ton of positivity in the field of autonomy, in the field of physical AI”
  • “First quarter shipments exceeded 4,700 sensors.”

Forward guidance

1 guided metrics

Management's latest ranges and targets are included below.

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $32.63M +25.8% YoY
Diluted EPS -$0.42
Gross margin 41.3% +12.7 pp YoY
Net income -$22.02M

Research materials

Open the source you need; every reader stays inside this workspace.

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
Revenue
second quarter
$32M – $35M

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$31.11M
Royalty$1.53M
Full-screen source Call document